What is Akums Drugs and Pharmaceuticals EBIT per Share?
Akums Drugs and Pharmaceuticals's EBIT per Share for the
six
months ended in Sep. 2024 was ₹13.96.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹17.19.
During the past 12 months, the average EBIT per Share Growth Rate of Akums Drugs and Pharmaceuticals was -7.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 16.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Akums Drugs and Pharmaceuticals's EBIT per Share or its related term are showing as below:
BOM:544222'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 16.2 Med: 16.2 Max: 16.2
Current: 16.2
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Akums Drugs and Pharmaceuticals was 16.20% per year. The lowest was 16.20% per year. And the median was 16.20% per year.
BOM:544222's 3-Year EBIT Growth Rate is ranked better than 63.8% of 826
companies
in the Drug Manufacturers industry
Industry Median: 6.65
vs BOM:544222: 16.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Akums Drugs and Pharmaceuticals EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹17.19
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akums Drugs and Pharmaceuticals (BOM:544222) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Akums Drugs and Pharmaceuticals EBIT per Share Related Terms
Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Akums Drugs and Pharmaceuticals Business Description
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:544222 has been successfully added to your